From Etest to Vitek 2: Impact of Enterococcal Linezolid Susceptibility Testing Methodology on Time to Active Therapy
Sign Up to like & getrecommendations! Published in 2020 at "Antimicrobial Agents and Chemotherapy"
DOI: 10.1128/aac.00302-20
Abstract: Different linezolid antimicrobial susceptibility testing (AST) methodologies yield various results. In 2018, we transitioned our linezolid AST methodology from the Etest to Vitek 2. We sought to evaluate the impact of this change on antibiotic… read more here.
Keywords: linezolid susceptibility; methodology; time active; susceptibility testing ... See more keywords
Ibrutinib Treatment in Early Stage CLL Prolongs Time to Active Disease.
Sign Up to like & getrecommendations! Published in 2021 at "Cancer discovery"
DOI: 10.1158/2159-8290.cd-rw2021-166
Abstract: Ibrutinib treatment extended time to active disease in early stage chronic lymphocytic leukemia. read more here.
Keywords: ibrutinib treatment; active disease; early stage; time active ... See more keywords